- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
1936
0 new
Companies with a Value score of at least 3, ordered by Value score
1,936 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NTR | €0.93 | 0.5% | 11.6% | €209.9m | €1.13 | PS8.2x | E67.3% | n/a | ||
600750 | CN¥22.53 | -0.2% | -1.1% | CN¥14.0b | CN¥28.00 | PE17.9x | E11.9% | 5.3% | ||
000739 | CN¥15.19 | -0.8% | 12.5% | CN¥17.6b | CN¥19.73 | PE16.4x | E15.6% | 2.1% | ||
VIA | €10.40 | -0.6% | -13.5% | €12.9b | €12.71 | PS0.9x | E52.4% | 4.4% | ||
2IVB | €9.55 | -5.4% | -43.4% | €981.1m | €15.73 | PS1x | E42.6% | 0% | ||
LDZA | €8.85 | 0% | -5.3% | €76.2b | €10.95 | PE17.3x | E21.7% | 2.1% | ||
K67 | €14.00 | -4.1% | -56.0% | €1.3b | €20.76 | PS0.5x | E60.9% | n/a | ||
AMPH | US$31.02 | -4.2% | -42.6% | US$1.5b | US$44.40 | PE9.5x | E5.6% | n/a | ||
0O9B | €9.09 | -0.08% | 5.6% | €1.9b | €11.93 | PS2x | E45.5% | 2.0% | ||
VIA | €10.37 | -2.0% | -14.5% | €12.9b | €12.67 | PS0.9x | E52.4% | 4.4% | ||
2DT | €7.40 | -1.3% | 38.3% | €2.4b | €10.05 | PS0.9x | E154.7% | 0% | ||
0A5V | US$10.87 | 0.7% | -16.6% | US$12.9b | US$13.29 | PS0.9x | E52.4% | 4.4% | ||
0O1O | €73.60 | 0.4% | -26.5% | €874.4m | €93.05 | PE18.5x | E7.5% | 1.2% | ||
4578 | JP¥7,325.00 | -7.6% | 30.8% | JP¥3.9t | JP¥9,486.36 | PE11.5x | E-1.1% | 1.6% | ||
VTRS | US$10.80 | 0.7% | -17.3% | US$12.9b | US$13.20 | PS0.9x | E52.4% | 4.4% | ||
300119 | CN¥17.84 | 8.2% | 14.8% | CN¥8.2b | CN¥21.42 | PE19.4x | E16.9% | 2.2% | ||
AVTR | US$17.87 | -6.7% | -24.8% | US$12.2b | US$24.85 | PE17.1x | E-2.9% | n/a | ||
OS1 | €45.40 | -10.1% | 32.7% | €3.9t | €58.80 | PE11.5x | E-1.1% | 1.6% | ||
TEV | €15.55 | -4.0% | 28.5% | €18.4b | €23.45 | PS1.1x | E67.7% | 0% | ||
002422 | CN¥27.75 | -0.4% | 6.0% | CN¥44.0b | CN¥43.29 | PE14.9x | E10.6% | 1.9% | ||
PFE | €24.35 | -2.1% | -5.8% | €144.7b | €29.73 | PE18x | E3.6% | 6.7% | ||
0Q1N | US$25.65 | 0.4% | -7.7% | US$144.7b | US$31.32 | PE18x | E3.6% | 6.7% | ||
MRK | US$83.01 | -4.9% | -35.0% | US$210.0b | US$116.38 | PE12.3x | E7.8% | 3.9% | ||
6MK | €79.10 | -6.9% | -33.2% | €210.0b | €110.90 | PE12.3x | E7.8% | 3.9% |